086900.KQ Medy-Tox Inc. Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
11:30
Sep 02
Sep 02
Medytox coverage initiation supports re-rating.
Eugene Investment & Securities initiated coverage on Medytox with a buy rating and 100,000 won target price. Known negatives such as litigation costs of about 45 billion won and US liquid toxin uncertainty are already reflected, while toxin export growth, third plant cost reductions, and improving profitability support downside and re-rating. The stock surged about 13% on the report.
HIGH
11:07
Sep 02
Sep 02
Medytox coverage start supports rerating.
Cha highlights Medytox after Eugene Investment Securities initiated coverage with a 100,000 target. The thesis is toxin export growth and improving profitability from the third plant, with already-known litigation risks priced in and the unknown positive being margin improvement.
MED
About 086900.KQ Analyst Coverage
Buzzberg tracks 086900.KQ (Medy-Tox Inc.) across 1 sources. 2 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 2 total trade ideas tracked. Past 7 days: 2 bullish. Latest voices: Cha Young-joo.